Skip to main content

Month: April 2022

Acarix publishes the annual report for 2021

Press release Malmö, Sweden, April 20, 2022   Acarix publishes the annual report for 2021 Today, Wednesday April 20, Acarix is publishing its Annual Report for 2021 on the company website www.acarix.com. An English translation of the annual report will be available on the company’s website no later than 29 April. https://acarix.com/investor/financial-reports-2/    For more information contact: Helen Ljungdahl Round, CEO, phone +1 267 809 1225, helen.round@acarix.com  The information was provided, through the agency of the above contact person, for publication at the time specified by the company’s news distributor, GlobeNewswire. About Acarix: Acarix is a Swedish medical device company that innovates solutions for rapid AI-based rule out of Coronary Artery Disease (CAD). The CE approved and FDA DeNovo cleared Acarix CADScor®System...

Continue reading

Marel: Q1 2022 results published on 27 April, virtual investor meeting on 28 April 2022

Marel hf. will publish its Q1 2022 interim condensed consolidated financial statements after market closing on 27 April 2022. Earnings conference call and webcast On Thursday 28 April 2022, at 8:30 am GMT (10:30 am CET), Marel will host a virtual investor meeting where senior management will give an overview of the financial results and operational highlights in the first quarter of the year. The meeting is webcast live on marel.com/webcast and a recording is available after the meeting on marel.com/ir. Members of the investment community can also join the meeting through a conference call by dialing:IS: +354 800 7437 (PIN 37176101#) NL: +31 20 721 9496 UK: +44 33 3300 9032 US: +1 631 913 1422 (PIN 37176101#)Financial calendarQ2 2022 – 27 July 2022         Q3 2022 – 2 November 2022 Q4 2022 – 8 February 2023         AGM – 22 March...

Continue reading

Form 8.3 – [Ideagen plc – 19 04 2022] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDEAGEN PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDEAGEN PLC AS AN ASSOCIATE OF THE...

Continue reading

Nasdaq Reports First Quarter 2022 Results; Delivers Strong Growth in Solutions Segments Revenue

Nasdaq Reports 1Q22 Results Nasdaq, Inc. reported financial results for the first quarter of 2022.NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) — Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the first quarter of 2022.First quarter 2022 net revenues¹ increased 5% compared to the first quarter of 2021. Solutions segments2 revenues increased 15%, including 13% organic growth and 4% contribution from the acquisition of Verafin, partially offset by a negative 2% FX impact. Annualized Recurring Revenue (ARR)3 increased 9% compared to the first quarter of 2021. Annualized SaaS revenues increased 12% and represented 34% of ARR. First quarter 2022 GAAP diluted earnings per share decreased 4% compared to the first quarter of 2021. First quarter 2022 non-GAAP4 diluted earnings per share increased 1% compared to the first...

Continue reading

Rogers Communications Reports First Quarter 2022 Results

 Focus on execution and economic growth delivers solid operational improvements in Wireless, Cable, and Media Wireless service revenue and adjusted EBITDA growth of 7%Postpaid mobile phone net adds of 66,000, up 44,000 from last year; improved Q1 postpaid mobile phone churn by 12 basis points to 0.71% Mobile phone ARPU1 of $57.25 up 3%Strong Cable financial results driven by improved execution; revenue up 2% and adjusted EBITDA up 13% Media revenue growth of 10% reflects continued recovery of sports Increasing full-year 2022 total service revenue, adjusted EBITDA, and free cash flow guidance2 pre-Shaw transaction, driven by better execution and economic growthTotal service revenue growth range now expected at 6% to 8%, compared to previous 4% to 6% Adjusted EBITDA growth range now expected at 8% to 10%, compared to previous 6%...

Continue reading

Pre-Feasibility Study supports long-life, high-value Cascabel project

OTTAWA, April 20, 2022 (GLOBE NEWSWIRE) — Cornerstone Capital Resources Inc. (“Cornerstone” or “the Company”) (TSXV:CGP) (OTC:CTNXF) (FWB:GWN1) is pleased to announce the results of the Pre-Feasibility Study (“PFS”) for the Cascabel copper-gold porphyry joint venture project in northern Ecuador in which Cornerstone has a 15% interest financed through to completion of a feasibility study and repayable out of Cornerstone’s share of project earnings, plus 6.85% of the shares of joint venture partner and Project operator SolGold Plc (“SolGold”), for a total direct and indirect interest in Cascabel of 20.8%. The PFS confirms the Cascabel project’s potential to be a large, low-cost, and long-life mining operation that is based on achievable, proven, and tested mining and processing assumptions. Once constructed, Cascabel is expected...

Continue reading

GasLog Partners LP Announces Date for First-Quarter 2022 Results, Conference Call and Webcast

MAJURO, Marshall Islands, April 20, 2022 (GLOBE NEWSWIRE) — GasLog Partners LP (“GasLog Partners” or the “Partnership”) (NYSE: GLOP) today announced that its financial results for the first quarter of 2022 will be released before the market opens on Thursday, April 28, 2022. GasLog Partners will host a conference call to discuss its results for the first quarter of 2022 at 8.30 a.m. EDT (3.30 p.m. EEST) on Thursday, April 28, 2022. The Partnership’s senior management will review the operational and financial performance for the period. Management’s presentation will be followed by a Q&A session. The dial-in numbers for the conference call are as follows: +1 866 374 5140 (USA)+44 20 3100 4191 (United Kingdom)+33 1 72 25 67 60 (France)+852 800 9337 52 (Hong Kong)+47 2396 4173 (Oslo) Conference ID: 90159316 A live webcast of...

Continue reading

Purpose Investments Celebrates One Year of World’s First Ether ETF with New Crypto Web Platform

Global crypto leader sees a bright future for Ethereum and begins to expand its digital product offering globally TORONTO, April 20, 2022 (GLOBE NEWSWIRE) — One year after launching the world’s first Ether spot ETF (Purpose Ether ETF; TSX ticker: ETHH), Purpose Investments Inc. (Purpose) today launched Purpose Crypto Corner, a new cryptocurrency hub on its website to help educate investors and advisors of all experience levels with digital assets. Purpose is also preparing to launch the first spot Bitcoin ETF in Australia with Cosmos Asset Management (Cosmos AM) for a target date of April 27. “We launched Purpose Ether ETF to give retail and institutional investors an easy way to access this amazing asset. Since launching, we’ve seen Ether’s price rise and fall, but despite its volatility, our long-term outlook is extremely optimistic....

Continue reading

OpGen’s Subsidiary Ares Genetics Commercially Launches New Sequencing and Analysis Services Globally

New services include pathogen identification, microbiome profiling and rapid turnaround sequencing of clinical isolates ROCKVILLE, Md., April 20, 2022 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today that its subsidiary, Ares Genetics (“Ares”), which strives to become a leader in bacterial genomics and AI-powered prediction of antimicrobial resistance (AMR), is commercially launching a series of new genome sequencing and analysis services globally.  In March 2022, the WHO emphasized the critical importance of microbial genome sequencing for pandemic preparedness in its new 10-year strategy1 for the global genomic surveillance of pathogens with pandemic and epidemic potential. To help...

Continue reading

Prosper Gold Signs Letter of Intent to Option Star Project

VANCOUVER, British Columbia, April 20, 2022 (GLOBE NEWSWIRE) — Prosper Gold Corp. (“Prosper” or the “Company”) (TSXV:PGX) is pleased to announce that it has entered into a non-binding letter of intent (the “LOI”) dated April 20th, 2022 with CAVU Mining Corp. (“CAVU”) (CNSX: CAVU), a company incorporated under the laws of British Columbia, to grant CAVU the right to earn and acquire Prosper’s 51% interest (the “Option”) in the Star Project located in the province of British Columbia (the “Proposed Transaction”). Under the terms of the LOI, CAVU may exercise the Option by: (i) issuing 1,250,000 common shares in the capital of CAVU to Prosper within seven days after execution of the Definitive Agreement (defined below) (the “Effective Date); and (ii) making cash payments to Prosper in the following amounts:$100,000 within seven...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.